Michael C Koons

age ~44

from York, PA

Get Report

Also known as:

Michael E Koons
Mike Koons

Phone and address:: 272 Point Cir, York, PA 17406
(717)8400918

Connected to:

Michael Koons Phones & Addresses

272 Point Cir, York, PA 17406 • (717)8400918
260 Coventry At Waterford, York, PA 17402 • (717)8400918
1047 Piketown Rd, Harrisburg, PA 17112 • (717)4691589
272 Point Cir, York, PA 17406

Work

Position:

Clerical/White Collar

Education

Degree:

Associate degree or higher

Images

Specialities

Buyer's Agent • Listing Agent

Real Estate Brokers

Michael Koons

view source

Specialties:

Buyer's Agent
Listing Agent

Name / Title

Company / Classification

Phones & Addresses

Michael Koons

York Area Taekwondo Academy
Fitness Center · Fitness Trainer

2810 E Prospect Rd, York, PA 17402
(717)3953044

Us Patents

Sublingual Films
view source
US Patent:

20120195955, Aug 2, 2012
Filed:

Apr 12, 2012
Appl. No.:

13/445656
Inventors:

Nathan John Bryson - Toronto, CA
Anthony John Giovinazzo - Oakville, CA
Scott David Barnhart - York PA, US
Michael Clinton Koons - York PA, US
Assignee:

ARx, LLC - Glen Rock PA
Cynapsus Therapeutics, Inc. - Toronto
International Classification:

A61K 31/435
A61P 25/16
A61K 9/70
US Classification:

424443, 514284
Abstract:

The invention features sublingual film formulations of dopamine agonists and methods of treating Parkinson's disease, tremors, restless leg syndrome, sexual dysfunction, and depressive disorders therewith.

Sublingual Films
view source
US Patent:

20130225626, Aug 29, 2013
Filed:

Apr 8, 2013
Appl. No.:

13/858638
Inventors:

Scott David Barnhart - York PA, US
Michael Clinton Koons - York PA, US
Assignee:

ARx, LLC - Glen Rock PA
Cynapsus Therapeutics, Inc. - Toronto
International Classification:

A61K 9/70
A61K 45/06
A61K 31/473
US Classification:

514284, 424443
Abstract:

The invention features sublingual film formulations of dopamine agonists and methods of treating Parkinson's disease, tremors, restless leg syndrome, sexual dysfunction, and depressive disorders therewith.

Pharmaceutical Compositions With Enhanced Stability Profiles
view source
US Patent:

20230130055, Apr 27, 2023
Filed:

Oct 21, 2022
Appl. No.:

17/971282
Inventors:

- Warren NJ, US
Rajesh Kumar Kainthan - Tappan NY, US
Vincent Buono - Basking Ridge NJ, US
Alexander Mark Schobel - Vero Beach FL, US
Michael Koons - York PA, US
Michael Goodrich - Leesburg VA, US
Gregory Tsodikov - East Windsor NJ, US
Assignee:

AQUESTIVE THERAPEUTICS, INC. - WARREN NJ
International Classification:

A61K 9/70
A61K 47/36
A61K 47/02
A61K 47/10
A61K 47/26
A61K 31/137
Abstract:

Soluble drug delivery films can exhibit an enhanced stability.

Methods Of Treating Parkinson's Disease By Administration Of Apomorphine To An Oral Mucosa
view source
US Patent:

20210205208, Jul 8, 2021
Filed:

Feb 18, 2021
Appl. No.:

17/179053
Inventors:

- Marlborough MA, US
Michael Clinton KOONS - York PA, US
Madhu Sudan HARIHARAN - Greensboro NC, US
Jordan DUBOW - Glencoe IL, US
Thierry BILBAULT - Cambridge MA, US
Anthony John GIOVINAZZO - Caledon, CA
International Classification:

A61K 9/00
A61K 47/02
A61K 31/473
A61K 47/14
A61K 47/26
A61K 9/70
A61K 47/36
A61K 45/06
A61P 25/16
A61K 47/10
A61K 47/18
A61K 47/38
Abstract:

Methods and pharmaceutical unit dosage forms for treating Parkinson's disease in a subject (e.g., an “off” episode in a subject having Parkinson's disease) are described. The pharmaceutical unit dosage forms are films having a first portion including particles containing an acid addition salt of apomorphine and a second portion containing a pH neutralizing agent. The pharmaceutical unit dosage forms can be flexible and have toughness greater than 100 g×mm. The methods can involve administering to a subject having Parkinson's disease a therapeutic dose sufficient to produce an apomorphine plasma concentrate of at least 2.64 ng/mL within 45 minutes after the administration. The subject may be identified as having low uptake, medium uptake, or high uptake of apomorphine administered via oral mucosa.

Methods Of Treating Parkinson's Disease By Administration Of Apomorphine To An Oral Mucosa
view source
US Patent:

20200069571, Mar 5, 2020
Filed:

Sep 9, 2019
Appl. No.:

16/564864
Inventors:

- Marlborough MA, US
Michael Clinton KOONS - York PA, US
Madhu Sudan HARIHARAN - Greensboro NC, US
Jordan DUBOW - Glencoe IL, US
Thierry BILBAULT - Cambridge MA, US
Anthony John GIOVINAZZO - Caledon, CA
International Classification:

A61K 9/00
A61K 47/02
A61K 31/473
A61K 47/14
A61K 47/26
A61K 9/70
A61P 25/16
A61K 47/10
A61K 47/18
A61K 47/38
A61K 47/36
A61K 45/06
Abstract:

Methods and pharmaceutical unit dosage forms for treating Parkinson's disease in a subject (e.g., an “off” episode in a subject having Parkinson's disease) are described. The pharmaceutical unit dosage forms are films having a first portion including particles containing an acid addition salt of apomorphine and a second portion containing a pH neutralizing agent. The pharmaceutical unit dosage forms can be flexible and have toughness greater than 100 g×mm. The methods can involve administering to a subject having Parkinson's disease a therapeutic dose sufficient to produce an apomorphine plasma concentrate of at least 2.64 ng/mL within 45 minutes after the administration. The subject may be identified as having low uptake, medium uptake, or high uptake of apomorphine administered via oral mucosa.

Sublingual Films
view source
US Patent:

20190365661, Dec 5, 2019
Filed:

May 10, 2019
Appl. No.:

16/409257
Inventors:

- Marlborough MA, US
Anthony John GIOVINAZZO - Caledon, CA
Scott David BARNHART - York PA, US
Michael Clinton KOONS - York PA, US
International Classification:

A61K 9/70
A61K 31/4415
A61F 13/00
A61K 47/02
A61K 9/00
A61K 47/14
A61K 47/38
A61K 31/4045
A61K 31/485
A61K 31/473
A61K 45/06
A61K 31/381
A61K 31/428
A61K 31/48
A61K 31/4985
A61K 31/506
A61J 1/03
A61J 7/00
B29C 39/18
B65D 65/38
A61K 47/10
A61K 47/12
A61K 47/18
A61K 47/22
A61K 47/36
B29C 39/38
B29C 43/30
B29C 43/52
B29C 65/70
B29C 65/00
Abstract:

The invention features sublingual film formulations of dopamine agonists and methods of treating Parkinson's disease, tremors, restless leg syndrome, sexual dysfunction, and depressive disorders therewith.

Methods Of Treating Parkinson's Disease By Administration Of Apomorphine To An Oral Mucosa
view source
US Patent:

20180133146, May 17, 2018
Filed:

Oct 20, 2017
Appl. No.:

15/789528
Inventors:

- Marlborough MA, US
Michael Clinton Koons - York PA, US
Madhu Sudan Hariharan - Greensboro NC, US
Jordan Dubow - Glencoe IL, US
Thierry Bilbault - Toronto, CA
Anthony John Giovinazzo - Caledon, CA
International Classification:

A61K 9/00
A61P 25/16
A61K 31/473
A61K 9/70
A61K 47/10
A61K 47/14
A61K 47/02
A61K 47/18
A61K 47/26
A61K 47/38
Abstract:

Methods and pharmaceutical unit dosage forms for treating Parkinson's disease in a subject (e.g., an “off” episode in a subject having Parkinson's disease) are described. The pharmaceutical unit dosage forms are films having a first portion including particles containing an acid addition salt of apomorphine and a second portion containing a pH neutralizing agent. The pharmaceutical unit dosage forms can be flexible and have toughness greater than 100 g×mm. The methods can involve administering to a subject having Parkinson's disease a therapeutic dose sufficient to produce an apomorphine plasma concentrate of at least 2.64 ng/mL within 45 minutes after the administration. The subject may be identified as having low uptake, medium uptake, or high uptake of apomorphine administered via oral mucosa.

Sublingual Films
view source
US Patent:

20160338972, Nov 24, 2016
Filed:

Aug 2, 2016
Appl. No.:

15/225992
Inventors:

- Toronto, CA
Anthony John GIOVINAZZO - Caledon, CA
Scott David BARNHART - York PA, US
Michael Clinton KOONS - York PA, US
International Classification:

A61K 9/70
A61K 31/473
A61K 47/38
A61K 47/22
A61K 47/14
A61K 47/10
A61K 47/36
A61K 47/02
A61K 47/18
A61K 47/12
A61K 31/4045
A61K 31/4985
A61K 31/48
A61K 31/506
A61K 31/428
A61K 45/06
B29C 39/18
B29C 39/38
B29C 43/30
B29C 43/52
B29C 65/70
B29C 65/00
B65D 65/38
A61J 1/03
A61K 9/00
Abstract:

The invention features sublingual film formulations of dopamine agonists and methods of treating Parkinson's disease, tremors, restless leg syndrome, sexual dysfunction, and depressive disorders therewith.

Resumes

Senior Formulation Scientist

view source

Location:

272 Point Cir, York, PA 17406

Industry:

Pharmaceuticals

Work:

Aquestive Therapeutics
Senior Formulation Scientist
Champions Oncology, Inc.
Manager, Formulation Services
Champions Oncology, Inc. Feb 2016 - Jun 2019
Supervisor, Formulation Services
Arx, Llc Mar 2005 - Jan 2016
Senior Formulation Chemist
Arx, Llc Dec 2008 - Dec 2012
Research and Development Chemist

Education:

The Johns Hopkins University 2014 - 2018
Master of Science, Masters, Biotechnology Lehigh University 2008 - 2011
Master of Science, Masters, Chemistry Penn State University 2000 - 2004
Bachelors, Bachelor of Science, Molecular Biology, Biochemistry

Skills:

Formulation
Gmp
Chemistry
Technology Transfer
R&D
Analytical Chemistry
Product Development
Quality System
Validation
Biotechnology
Polymers
Chromatography
Lifesciences
Polymer Chemistry
Coatings
Process Simulation
Mass Spectrometry
Capa
Quality Control
Hplc
Materials
Iso
Gas Chromatography
Materials Science
Commercialization
Laboratory
Design of Experiments
Chemical Engineering
Characterization
Fda
Six Sigma
V&V
Process Engineering
Pharmaceutical Industry
Medical Devices
Uv/Vis
Sop
Spectroscopy
Lims
Dissolution
Adhesives
Drug Delivery
Wet Chemistry
Pharmaceutics
Regulatory Affairs
Good Laboratory Practice
Microsoft Office
Cross Functional Team Leadership
Operations Management
Project Management
Uv
Polymer Science
Differential Scanning Calorimetry
Polymer Characterization
Tga
Physical Chemistry
Plastics

Interests:

Education

Languages:

English
French

Sales Associate

view source

Location:

Katy, TX

Industry:

Real Estate

Work:

Kb Home
Sales Associate
Perry Homes, Inc. Aug 2009 - Apr 2012
Sales Manager
David Weekley Homes Sep 2004 - Aug 2009
Senior Sales Consultant - Build on Your Lot
Flooring America Jan 2002 - Jul 2004
Sales Manager

Education:

Houston Community College 1984 - 1986
Houston Community College 1983 - 1986

Skills:

Negotiation
New Home Sales
Customer Satisfaction
Real Estate
Sales
Residential Homes
Contract Negotiation
Sellers
Sales Management
Selling
Buyers
First Time Home Buyers
Single Family Homes
Investment Properties
Referrals
Customer Service
Process Scheduler
Real Estate Development
Construction
New Homes
Real Estate Transactions
Sales Process
Land Acquisition
Condos
Property Management
Homebuilding
Marketing
Account Management
Relocation
Resellers
Buyer Representation
New Home Construction
Qualifying Prospects
Cold Calling
Luxury
Commercial Real Estate
Investors
Listings
Move Up Buyers
Short Sales
Property
Real Property
Townhomes
Home Staging
Vacation Homes

Interests:

Children
Economic Empowerment
Education
Science and Technology
Disaster and Humanitarian Relief
Animal Welfare